Immundiagnostik, Inc. Partners with BioPorto Diagnostics A/S to Expand Renal Research Offering
Immundiagnostik, Inc. has partnered with BioPorto Diagnostics A/S to expand its product offering to include BioPorto’s highly regarded NGAL ELISAs.
Category: Company News
Discover the latest news and updates from Immundiagnostik, Inc.
Research Focus: Use of IDK ELISAs to Detect Human AMP in the Intestinal Lumen
A study by Julie S. Hong, et al. from Weiner Lab at Columbia University investigated the application of enzyme-linked immunosorbent assays (ELISAs) to detect human AMP in the intestinal lumen.
Immundiagnostik, Inc. Launches New and Improved Website
The new website offers a simplified design, an improved browsing and shopping experience, and a new chat tool for enhanced customer support.
Immundiagnostik at AACC 2023: A Recap
A recap of all the highlights at AACC 2023 including featured products, events, and more.
Immundiagnostik, Inc. Celebrates 5 Years in North America
Immundiagnostik, Inc. is celebrating its 5th anniversary in North America!
Assessing the Effectiveness of Vitamin B Supplementation on Fatigue in Athletes
Hendrik Seidl, Head of HPLC and Micronutrients at Immundiagnostik AG, discusses his poster which explores the effectiveness of vitamin B supplementation on fatigue symptoms in professional athletes.
WTF: Why the Frog? The Story of Franz
Have you ever wondered why we include a frog in some of our marketing materials? Read our post to find out!
Research Focus: IDKmonitor® Adalimumab ELISAs
Immundiagnostik’s IDKmonitor® Adalimumab ELISAs were featured in a study aimed to explore the relationship between adalimumab drug levels and biologic remission for Crohn’s disease.